A detailed history of Rhumbline Advisers transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 89,399 shares of HCAT stock, worth $620,429. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89,399
Previous 91,111 1.88%
Holding current value
$620,429
Previous $582,000 24.91%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$5.48 - $8.83 $9,381 - $15,116
-1,712 Reduced 1.88%
89,399 $727,000
Q2 2024

Aug 01, 2024

BUY
$5.53 - $7.28 $41,967 - $55,247
7,589 Added 9.09%
91,111 $582,000
Q1 2024

May 09, 2024

BUY
$7.44 - $11.21 $12,223 - $18,418
1,643 Added 2.01%
83,522 $628,000
Q4 2023

Feb 08, 2024

BUY
$6.71 - $10.16 $154 - $233
23 Added 0.03%
81,879 $758,000
Q3 2023

Nov 09, 2023

BUY
$9.35 - $14.32 $36,137 - $55,346
3,865 Added 4.96%
81,856 $828,000
Q2 2023

Aug 08, 2023

SELL
$9.86 - $13.12 $94,833 - $126,188
-9,618 Reduced 10.98%
77,991 $974,000
Q1 2023

May 11, 2023

SELL
$10.23 - $14.76 $135,680 - $195,761
-13,263 Reduced 13.15%
87,609 $1.02 Million
Q4 2022

Feb 14, 2023

BUY
$6.86 - $11.32 $128,144 - $211,457
18,680 Added 22.73%
100,872 $1.07 Million
Q3 2022

Nov 10, 2022

BUY
$9.3 - $18.27 $49,569 - $97,379
5,330 Added 6.93%
82,192 $797,000
Q2 2022

Aug 11, 2022

BUY
$11.79 - $27.63 $279,104 - $654,084
23,673 Added 44.51%
76,862 $1.11 Million
Q1 2022

May 12, 2022

BUY
$20.67 - $40.33 $84,622 - $165,111
4,094 Added 8.34%
53,189 $1.39 Million
Q4 2021

Feb 10, 2022

BUY
$36.68 - $54.02 $15,002 - $22,094
409 Added 0.84%
49,095 $1.95 Million
Q3 2021

Nov 12, 2021

BUY
$49.57 - $58.15 $251,319 - $294,820
5,070 Added 11.62%
48,686 $2.44 Million
Q2 2021

Aug 05, 2021

BUY
$47.17 - $58.64 $336,463 - $418,279
7,133 Added 19.55%
43,616 $2.42 Million
Q1 2021

May 06, 2021

SELL
$42.51 - $54.07 $163,110 - $207,466
-3,837 Reduced 9.52%
36,483 $1.71 Million
Q4 2020

Feb 10, 2021

BUY
$31.9 - $44.89 $31,325 - $44,081
982 Added 2.5%
40,320 $1.76 Million
Q3 2020

Nov 12, 2020

SELL
$28.55 - $36.91 $145,890 - $188,610
-5,110 Reduced 11.5%
39,338 $1.44 Million
Q2 2020

Aug 13, 2020

BUY
$24.0 - $32.87 $514,152 - $704,174
21,423 Added 93.04%
44,448 $1.3 Million
Q1 2020

May 06, 2020

BUY
$17.8 - $37.6 $274,440 - $579,716
15,418 Added 202.68%
23,025 $602,000
Q4 2019

Feb 05, 2020

BUY
$26.44 - $40.63 $6,900 - $10,604
261 Added 3.55%
7,607 $264,000
Q3 2019

Oct 23, 2019

BUY
$30.31 - $48.63 $222,657 - $357,235
7,346 New
7,346 $232,000

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $380M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.